With offices in Harvard Innovation Launch Lab and UMass Lowell Innovation Hub, Harmonus is combining sophisticated image guidance software and point-of-care fabrication of personalized needle guides significantly to improve the diagnosis and treatment of prostate amd other cancers. The Harmonus System for MRI-guided biopsies can significantly improve the diagnosis and treatment through precise, safe tumor targeting, user-friendly navigation software and image based records. Harmonus cost-effectively solves the standard biopsy problem of ‘blind’ prostate sampling, which leads to repeat biopsies, inaccurate cancer staging, overtreatment, and serious complications.
